Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SCD Probiotics is a global biotechnology company specializing in the development and manufacturing of beneficial microbial and probiotic technologies. The company utilizes a proprietary fermentation process to create multi-strain microbial consortia that are applied across human health, agriculture, livestock, and environmental sectors. Their products are designed to restore ecological balance and improve health outcomes by leveraging the natural power of beneficial bacteria. SCD Probiotics operates a large-scale manufacturing facility and maintains a significant international presence through a network of licensees and partners. The company's business model includes both direct product sales and the licensing of its core microbial technologies to global industrial partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SCD.